NCT00158652
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +22 more
- Locations
-
- CHU de Tours Tours, France
- Institut Gustave Roussy Villejuif, France
Clinical trial condition
Pharyngeal Neoplasms
Explore clinical trials studying Pharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.
734 public trials
231 recruiting studies
Pharyngeal Neoplasms trial results
NCT01449942
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- XiangYa Hospital, Central South University Changsha, Hunan, China
NCT00169247
- Conditions
- Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Hypopharynx Cancer, +12 more
- Locations
-
- Centre Oscar Lambret Lille, France
- Centre René Gauducheau Nantes, France
- CHU de Tours Tours, France
NCT00436293
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sanofi-Aventis Hong Kong
NCT00005647
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Carcinoma, +38 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00700440
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China
NCT00123864
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
NCT00002901
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +54 more
- Locations
-
- Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
NCT00006361
- Conditions
- Carcinoma, Carcinoma of Unknown Primary, Carcinoma, Squamous Cell, +23 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
NCT00436800
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sanofi-Aventis Administrative Office Hong Kong